Pfm Health Sciences, LP Cytokinetics Inc Transaction History
Pfm Health Sciences, LP
- $1.71 Billion
- Q3 2024
A detailed history of Pfm Health Sciences, LP transactions in Cytokinetics Inc stock. As of the latest transaction made, Pfm Health Sciences, LP holds 1,757,192 shares of CYTK stock, worth $85.6 Million. This represents 5.44% of its overall portfolio holdings.
Number of Shares
1,757,192
Previous 1,757,192
-0.0%
Holding current value
$85.6 Million
Previous $95.2 Million
2.55%
% of portfolio
5.44%
Previous 4.89%
Shares
7 transactions
Others Institutions Holding CYTK
# of Institutions
404Shares Held
124MCall Options Held
4.6MPut Options Held
2.43M-
Black Rock Inc. New York, NY14.7MShares$715 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$573 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.69MShares$472 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.77MShares$379 Million0.07% of portfolio
-
State Street Corp Boston, MA6.46MShares$315 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.58B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...